FIRST TREATMENT APPROVED FOR PEOPLE WITH SPECIFIC TYPE OF ADVANCED BLADDER CANCER IN MORE THAN 30 YEARS
New bladder
cancer treatment works with body's immune system in the fight against
cancer
Bladder cancer is the fifth most common
cancer in the United States and, until recently, those with the advanced form
of the disease might have received the same type of treatment as they would
have in the 1980s. The FDA approves TECENTRIQ™ first new treatment in
more than 30 years for specific bladder cancer.
Dr. Arjun Balar, medical oncologist at NYU
Langone and cancer patient Kevin Williamson
discuss this new treatment. Article/Video
Comments